Wei Wang

Also affiliated with Beijing Friendship Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?”.

Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?

Genes & Diseases(2023)10.1016/j.gendis.2023.101156

N/A

0.312DataRank · unranked

7 citations

Yi Du, Sayantap Datta, Josef F. Fowler, Hannah T. Sang, Najah Albadari +4 more

Molecular targeting therapies for neuroblastoma: Progress and challenges

Medicinal Research Reviews(2020)10.1002/med.21750

N/A

0DataRank · unranked

395 citations

Wei Wang, Gang Liu, Xinjie Wang, Wa Xian, Frank McKeon +4 more

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope

Cancer Letters(2020)10.1016/j.canlet.2020.09.023

N/A

0DataRank · unranked

115 citations

Wei Wang, Gang Liu, Wa Xian, Frank McKeon, Jia Zhou +2 more

Targeting MDM2, RAS, and PCNA for cancer targeted therapy: pan-cancer approaches vs. cancer-specific strategies

Frontiers in Pharmacology(2025)10.3389/fphar.2025.1663766

N/A

0DataRank · unranked

0 citations

Abigail Alley, Na Sun, Meheret Tadesse, Xinshi Wang, Ruiwen Zhang +1 more